Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

COVID-19 led to fewer dermatology admissions in Hubei, China, with more severe cases and increased eczema due to mask use and hand disinfectants.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Elderly people, especially with chronic conditions, are more at risk of severe COVID-19 complications and need preventive care and social support.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Rare genetic variants contribute to male pattern hair loss, but there's no link to severe COVID-19.

Age, gender, obesity, and smoking increase the risk of severe COVID-19.

Men and minority groups face higher risks and severe outcomes from SARS-CoV, MERS-CoV, and COVID-19.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Severe COVID-19 often leads to hair loss in India.

Long COVID causes lasting symptoms in many body systems, needing more research for better treatments.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Testosterone's effects on COVID-19 are unclear and need more research.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.